<DOC>
	<DOCNO>NCT00802542</DOCNO>
	<brief_summary>The purpose study prove practice effectiveness Atacand 16 mg reduce blood pressure 4 week administration importance administration adequate dos</brief_summary>
	<brief_title>In-practice Evaluation Atacand 16mg Antihypertensive Effect</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Candesartan cilexetil</mesh_term>
	<mesh_term>Candesartan</mesh_term>
	<mesh_term>Antihypertensive Agents</mesh_term>
	<criteria>Adult patient mild ( 140159/9099 mgHg ) moderate ( 160179/100109 mmHg ) essential hypertension , already treat Atacand 8mg 24 week , reach blood pressure treatment goal least &lt; 140/90 mgHg doctor decide Signed date Patient Informed Consent ( ICF ) Hypersensitivity active substance excipients Atacand .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>Hypertension</keyword>
	<keyword>blood pressure</keyword>
	<keyword>Atacand</keyword>
</DOC>